Ying Wang
4 Papers
Ying Wang is an academic researcher. The author has contributed to research in topics: Medicine & Neuroprotection. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Neuroprotection by cattle encephalon glycoside and ignotin beyond the time window of thrombolysis in ischemic stroke.
TL;DR: The results suggest that CEGI has an effective neuroprotective effect on ischemic stroke when administered after the time window of thrombolysis.
7
Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part I: Event Rates and Clinical Outcome
Kelly D. Flemming,Helen Kim,Stephanie F Hage,Jay Mandrekar,Serena Kinkade,Romuald Girard,Michel T. Torbey,Judy Huang,John Huston,Yunhong Shu,G. Lanzino,Reed G Selwyn,Blaine L. Hart,Marc C. Mabray,James Feghali,Haris I. Sair,Jared Narvid,Janine M. Lupo,Justine Lee,Agnieszka Stadnik,R. J. Alcazar-Felix,Robert Shenkar,Karen Lane,Nichol McBee,Kevin Treine,Noeleen Ostapkovich,Ying Wang,Richard E. Thompson,James I. Koenig,Timothy Carroll,Dan Hanley,Issam A. Awad +31 more
TL;DR: No score change was highly sensitive or specific for SH and could not be used as a primary end point in a trial, and functional outcomes and patient-reported outcomes generally improved over 2 years.
6
Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part II: Biomarkers and Trial Modeling
Stephanie F Hage,Serena Kinkade,Romuald Girard,Kelly D. Flemming,Helen Kim,Michel T. Torbey,Judy Huang,John Huston,Yunhong Shu,Reed G Selwyn,Blaine L. Hart,Marc C. Mabray,James Feghali,Haris I. Sair,Jared Narvid,Janine M. Lupo,Justine Lee,Agnieszka Stadnik,R. J. Alcazar-Felix,Robert Shenkar,Nicholas Hobson,Dorothy Debiasse,Karen Lane,Nichol McBee,Kevin Treine,Noeleen Ostapkovich,Ying Wang,Richard E. Thompson,James I. Koenig,Timothy Carroll,Dan Hanley,Issam A. Awad +31 more
TL;DR: Assessment of QSM change is feasible and sensitive to recurrent bleeding in cavernous malformations and DCEQP change had lower sensitivity for SH and asymptomatic change than QSM change and greater variance.
3
Cavernous Angioma Symptomatic Hemorrhage (CASH) Trial Readiness II: Imaging Biomarkers and Trial Modeling
Stephanie F Hage,Romuald Girard,Kelly D. Flemming,Helen Kim,Michel T. Torbey,Judy Huang,John Huston,Yunhong Shu,Reed Selwyn,Blaine L. Hart,Marc C. Mabray,James Feghali,Haris I. Sair,Jared Narvid,Janine M. Lupo,Justine Lee,Agnieszka Stadnik,Roberto Alcázar,Robert Shenkar,Nicholas Hobson,Dorothy Debiasse,Karen Lane,Nichol McBee,Kevin Treine,Noeleen Ostapkovich,Ying Wang,Richard E. Thompson,Carolina Mendoza-Puccini,James I. Koenig,Timothy J. Carroll,Daniel F Hanley,Issam A. Awad +31 more
TL;DR: In this paper , Quantitative susceptibility mapping (QSM) and dynamic contrast enhanced quantitative perfusion (DCEQP) MRI sequences assessing iron deposition and vascular permeability were previously correlated with new hemorrhage in cavernous angiomas.